Pradyumna Phatak
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Hemochromatosis | 19 | 1994 | 8 |
Why?
| Iron Overload | 8 | 2000 | 3 |
Why?
| Histocompatibility Antigens Class I | 7 | 1997 | 32 |
Why?
| Iron Chelating Agents | 6 | 2007 | 5 |
Why?
| Membrane Proteins | 7 | 1997 | 233 |
Why?
| Benzoic Acids | 3 | 2007 | 1 |
Why?
| Triazoles | 3 | 2007 | 31 |
Why?
| Ferritins | 9 | 1994 | 36 |
Why?
| Blood Transfusion | 4 | 2007 | 59 |
Why?
| Mass Screening | 6 | 1994 | 125 |
Why?
| Iron | 7 | 1994 | 75 |
Why?
| Point Mutation | 3 | 1997 | 122 |
Why?
| Bone Marrow Diseases | 1 | 2009 | 31 |
Why?
| Sex Chromosome Aberrations | 1 | 2008 | 5 |
Why?
| Chromosomes, Human, X | 1 | 2008 | 9 |
Why?
| Genetic Testing | 1 | 2008 | 49 |
Why?
| Thalassemia | 3 | 1997 | 11 |
Why?
| Leukemia, Myeloid, Acute | 2 | 1999 | 53 |
Why?
| Myelodysplastic Syndromes | 1 | 2009 | 27 |
Why?
| Homozygote | 6 | 1996 | 68 |
Why?
| Genotype | 7 | 1997 | 175 |
Why?
| Mutation, Missense | 3 | 2002 | 59 |
Why?
| Humans | 45 | 1988 | 1856 |
Why?
| Middle Aged | 23 | 1989 | 1161 |
Why?
| Lung Diseases, Interstitial | 1 | 2005 | 11 |
Why?
| Actins | 6 | 1988 | 112 |
Why?
| Transferrin | 6 | 1994 | 22 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2005 | 26 |
Why?
| Liver | 7 | 1994 | 248 |
Why?
| Adult | 23 | 1994 | 1317 |
Why?
| Pyrimidines | 1 | 2005 | 49 |
Why?
| Piperazines | 1 | 2005 | 57 |
Why?
| HLA Antigens | 3 | 1996 | 38 |
Why?
| Anemia | 2 | 1997 | 60 |
Why?
| Male | 25 | 1989 | 1553 |
Why?
| Female | 22 | 1994 | 1643 |
Why?
| Osteoarthritis | 1 | 2003 | 51 |
Why?
| Cost-Benefit Analysis | 4 | 1994 | 118 |
Why?
| Aged | 12 | 1994 | 988 |
Why?
| Lymphoma | 2 | 1997 | 96 |
Why?
| Antineoplastic Agents | 1 | 2005 | 190 |
Why?
| Prevalence | 5 | 1994 | 281 |
Why?
| Corynebacterium Infections | 1 | 1998 | 10 |
Why?
| Infectious Mononucleosis | 1 | 1998 | 9 |
Why?
| Parvoviridae Infections | 1 | 1998 | 12 |
Why?
| Phenotype | 5 | 1997 | 303 |
Why?
| Immunoblastic Lymphadenopathy | 1 | 1997 | 4 |
Why?
| Giant Lymph Node Hyperplasia | 1 | 1997 | 3 |
Why?
| Sarcoidosis | 1 | 1997 | 29 |
Why?
| Cation Transport Proteins | 2 | 2005 | 17 |
Why?
| Anemia, Sideroblastic | 1 | 1997 | 6 |
Why?
| Primary Myelofibrosis | 1 | 1997 | 5 |
Why?
| Splenectomy | 1 | 1997 | 29 |
Why?
| Copper | 1 | 1997 | 36 |
Why?
| Burkitt Lymphoma | 3 | 1989 | 36 |
Why?
| Heterozygote | 2 | 2003 | 80 |
Why?
| Lymph Nodes | 1 | 1997 | 106 |
Why?
| Liver Cirrhosis | 3 | 2002 | 48 |
Why?
| Lymphocyte Activation | 1 | 1997 | 137 |
Why?
| Phlebotomy | 2 | 2008 | 5 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1994 | 34 |
Why?
| Biopsy | 4 | 1994 | 207 |
Why?
| Lymphocytes | 1 | 1994 | 142 |
Why?
| Translocation, Genetic | 2 | 1994 | 35 |
Why?
| Drug Costs | 2 | 2008 | 22 |
Why?
| Economics, Pharmaceutical | 2 | 2007 | 7 |
Why?
| Amino Acid Substitution | 2 | 2005 | 68 |
Why?
| Aged, 80 and over | 4 | 1994 | 599 |
Why?
| Deferoxamine | 2 | 2007 | 16 |
Why?
| Administration, Oral | 2 | 2007 | 170 |
Why?
| Mandibular Nerve | 1 | 2011 | 2 |
Why?
| Cranial Nerve Diseases | 1 | 2011 | 6 |
Why?
| Tretinoin | 3 | 1995 | 48 |
Why?
| Creatinine | 1 | 2010 | 69 |
Why?
| Safety | 1 | 2010 | 80 |
Why?
| Cross-Sectional Studies | 3 | 1998 | 253 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2009 | 8 |
Why?
| Medication Adherence | 1 | 2009 | 19 |
Why?
| Adolescent | 8 | 1994 | 891 |
Why?
| Antibodies, Monoclonal | 1 | 1994 | 241 |
Why?
| International Classification of Diseases | 1 | 2009 | 8 |
Why?
| Erythrocyte Transfusion | 1 | 2009 | 29 |
Why?
| von Willebrand Diseases | 2 | 1996 | 8 |
Why?
| Early Diagnosis | 1 | 2008 | 23 |
Why?
| Risk Factors | 2 | 2003 | 555 |
Why?
| Chelation Therapy | 1 | 2008 | 6 |
Why?
| Dose-Response Relationship, Drug | 2 | 1996 | 431 |
Why?
| Mutation | 4 | 1996 | 340 |
Why?
| Anemia, Sickle Cell | 1 | 2008 | 33 |
Why?
| Protein Kinase C | 2 | 1988 | 93 |
Why?
| Treatment Outcome | 4 | 1997 | 661 |
Why?
| Karyotyping | 1 | 2008 | 47 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2008 | 53 |
Why?
| Treatment Refusal | 1 | 2007 | 31 |
Why?
| Granulocytes | 3 | 1995 | 46 |
Why?
| Quality of Life | 2 | 2000 | 188 |
Why?
| Genetic Predisposition to Disease | 1 | 2009 | 131 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2009 | 176 |
Why?
| Case-Control Studies | 1 | 2009 | 283 |
Why?
| Child | 7 | 1994 | 749 |
Why?
| Dyspnea | 1 | 2005 | 13 |
Why?
| Primary Health Care | 2 | 1998 | 151 |
Why?
| Interleukin-8 | 3 | 1993 | 54 |
Why?
| Retrospective Studies | 2 | 2008 | 653 |
Why?
| Oxygen Inhalation Therapy | 1 | 2005 | 33 |
Why?
| Radiography, Thoracic | 1 | 2005 | 41 |
Why?
| T-Lymphocytes | 1 | 1988 | 182 |
Why?
| Gene Frequency | 2 | 1996 | 42 |
Why?
| Diagnosis, Differential | 2 | 1997 | 402 |
Why?
| DNA Mutational Analysis | 2 | 1996 | 110 |
Why?
| Chondrocalcinosis | 1 | 2003 | 4 |
Why?
| Australia | 1 | 2002 | 27 |
Why?
| Hand | 1 | 2003 | 37 |
Why?
| Continental Population Groups | 1 | 2002 | 85 |
Why?
| Heart Diseases | 1 | 2002 | 92 |
Why?
| Genitalia, Female | 1 | 2000 | 18 |
Why?
| Age Factors | 2 | 2000 | 480 |
Why?
| N-Formylmethionine Leucyl-Phenylalanine | 3 | 1993 | 14 |
Why?
| Genital Diseases, Female | 1 | 2000 | 22 |
Why?
| Family Health | 1 | 2000 | 69 |
Why?
| Cohort Studies | 2 | 1997 | 332 |
Why?
| Meninges | 1 | 1999 | 12 |
Why?
| Statistics, Nonparametric | 1 | 2000 | 141 |
Why?
| Child, Preschool | 3 | 1994 | 554 |
Why?
| Meningeal Neoplasms | 1 | 1999 | 30 |
Why?
| Multiple Myeloma | 1 | 1999 | 44 |
Why?
| Bone Marrow Examination | 1 | 1998 | 11 |
Why?
| Blood Cell Count | 1 | 1998 | 31 |
Why?
| Leukemia, Promyelocytic, Acute | 2 | 1995 | 16 |
Why?
| Feasibility Studies | 1 | 1998 | 144 |
Why?
| Heterozygote Detection | 1 | 1997 | 16 |
Why?
| Bone Marrow Cells | 1 | 1998 | 92 |
Why?
| von Willebrand Factor | 1 | 1996 | 34 |
Why?
| Brain Neoplasms | 1 | 1999 | 116 |
Why?
| Linkage Disequilibrium | 1 | 1996 | 8 |
Why?
| Multiple Endocrine Neoplasia Type 1 | 1 | 1996 | 5 |
Why?
| Purpura, Thrombocytopenic | 1 | 1996 | 11 |
Why?
| Chemotaxis | 1 | 1996 | 20 |
Why?
| Anemia, Iron-Deficiency | 1 | 1996 | 28 |
Why?
| United States | 4 | 1996 | 604 |
Why?
| Infant | 2 | 1994 | 464 |
Why?
| Spleen | 1 | 1997 | 129 |
Why?
| Phagocytosis | 1 | 1996 | 51 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 1995 | 34 |
Why?
| Bloodletting | 1 | 1994 | 1 |
Why?
| Factor VIII | 1 | 1996 | 28 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 1994 | 11 |
Why?
| Chromosome Mapping | 1 | 1996 | 107 |
Why?
| Dimethyl Sulfoxide | 1 | 1995 | 30 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 1994 | 14 |
Why?
| Genes, Recessive | 1 | 1994 | 33 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 1994 | 11 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 1994 | 14 |
Why?
| Algorithms | 1 | 1998 | 226 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 1994 | 19 |
Why?
| Dexamethasone | 1 | 1996 | 109 |
Why?
| Ionomycin | 1 | 1994 | 12 |
Why?
| Life Expectancy | 1 | 1994 | 20 |
Why?
| New York | 1 | 1998 | 422 |
Why?
| Patient Selection | 1 | 1996 | 155 |
Why?
| Intracellular Membranes | 1 | 1994 | 44 |
Why?
| Leukemia | 1 | 1995 | 70 |
Why?
| Protein Kinase Inhibitors | 1 | 1994 | 59 |
Why?
| Calcium | 3 | 1993 | 208 |
Why?
| Patient Compliance | 2 | 1998 | 113 |
Why?
| Predictive Value of Tests | 2 | 1998 | 321 |
Why?
| Decision Making | 1 | 1994 | 130 |
Why?
| Neutrophils | 1 | 1993 | 114 |
Why?
| Chin | 1 | 2011 | 6 |
Why?
| Lip | 1 | 2011 | 9 |
Why?
| Sensitivity and Specificity | 1 | 1994 | 427 |
Why?
| Epidemiologic Measurements | 1 | 2008 | 1 |
Why?
| Sphingosine | 1 | 1988 | 16 |
Why?
| Cysteine | 1 | 2009 | 52 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1988 | 83 |
Why?
| Cardiomyopathies | 1 | 2008 | 43 |
Why?
| Pyridones | 1 | 2007 | 7 |
Why?
| Fatal Outcome | 2 | 1996 | 86 |
Why?
| Cell Transformation, Neoplastic | 1 | 1989 | 86 |
Why?
| Lymphoma, Follicular | 1 | 1989 | 27 |
Why?
| Databases, Factual | 1 | 2008 | 102 |
Why?
| Protein Conformation | 1 | 1988 | 123 |
Why?
| beta-Thalassemia | 1 | 2007 | 5 |
Why?
| Drug Utilization Review | 1 | 2007 | 6 |
Why?
| Insurance Claim Review | 1 | 2007 | 18 |
Why?
| Ethnic Groups | 1 | 2008 | 95 |
Why?
| Markov Chains | 1 | 2007 | 25 |
Why?
| Cost of Illness | 1 | 2007 | 54 |
Why?
| Infusions, Intravenous | 1 | 2007 | 87 |
Why?
| Enzyme Activation | 1 | 1988 | 177 |
Why?
| Drug Administration Schedule | 1 | 2007 | 191 |
Why?
| Genes, Dominant | 1 | 2005 | 68 |
Why?
| Pedigree | 1 | 2005 | 84 |
Why?
| Delivery of Health Care | 1 | 2007 | 102 |
Why?
| Signal Transduction | 1 | 1993 | 313 |
Why?
| Alanine Transaminase | 1 | 2003 | 20 |
Why?
| Liver Function Tests | 1 | 2003 | 25 |
Why?
| Aspartate Aminotransferases | 1 | 2003 | 33 |
Why?
| ROC Curve | 1 | 2003 | 80 |
Why?
| Regression Analysis | 1 | 2003 | 256 |
Why?
| Menstruation | 1 | 2000 | 10 |
Why?
| Logistic Models | 1 | 2003 | 251 |
Why?
| Labor, Obstetric | 1 | 2000 | 22 |
Why?
| Cell Differentiation | 2 | 1995 | 262 |
Why?
| False Positive Reactions | 1 | 1998 | 71 |
Why?
| Informed Consent | 1 | 1998 | 62 |
Why?
| Radiotherapy | 1 | 1999 | 73 |
Why?
| Education, Medical, Continuing | 1 | 1998 | 54 |
Why?
| Cerebral Cortex | 1 | 1999 | 108 |
Why?
| Ristocetin | 1 | 1996 | 6 |
Why?
| Bleeding Time | 1 | 1996 | 10 |
Why?
| HL-60 Cells | 1 | 1996 | 28 |
Why?
| Biological Markers | 1 | 1998 | 262 |
Why?
| L-Selectin | 1 | 1995 | 11 |
Why?
| DNA Probes | 1 | 1996 | 61 |
Why?
| Genetic Markers | 1 | 1996 | 78 |
Why?
| Questionnaires | 1 | 2000 | 360 |
Why?
| Integrins | 1 | 1995 | 35 |
Why?
| Nitroblue Tetrazolium | 1 | 1995 | 4 |
Why?
| Antigens, Surface | 1 | 1995 | 51 |
Why?
| Dimerization | 1 | 1996 | 92 |
Why?
| Alleles | 1 | 1996 | 108 |
Why?
| Immunophenotyping | 1 | 1995 | 66 |
Why?
| Cell Size | 1 | 1995 | 68 |
Why?
| Cell Adhesion Molecules | 1 | 1995 | 48 |
Why?
| Pregnancy | 1 | 2000 | 455 |
Why?
| Chemotaxis, Leukocyte | 1 | 1995 | 23 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 121 |
Why?
| Neoplasm Metastasis | 1 | 1996 | 112 |
Why?
| Pertussis Toxin | 1 | 1993 | 25 |
Why?
| Virulence Factors, Bordetella | 1 | 1993 | 22 |
Why?
| Oxidation-Reduction | 1 | 1995 | 124 |
Why?
| Polymerase Chain Reaction | 1 | 1996 | 279 |
Why?
| Bone Marrow | 1 | 1994 | 109 |
Why?
| Polymers | 1 | 1993 | 60 |
Why?
| Tumor Cells, Cultured | 1 | 1995 | 233 |
Why?
| Molecular Sequence Data | 1 | 1996 | 404 |
Why?
| Follow-Up Studies | 1 | 1989 | 553 |
Why?
| Time Factors | 1 | 1989 | 896 |
Why?
|
|
Phatak's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
